The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties

被引:9
|
作者
Maes, M
Kenis, G
Bosmans, E
机构
[1] Univ Hosp Maastricht, Dept Psychiat, NL-6202 AZ Maastricht, Netherlands
[2] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[3] Clin Res Ctr Mental Hlth, Limburg, Belgium
关键词
serotonin; moduline; cytokine; interferon; tumor necrosis factor; cAMP;
D O I
10.1006/cyto.2002.1053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Serotonin (5-HT) has negative immunoregulatory effects by reducing the interferon-gamma (IFNgamma)/interleukin-10 (IL-10) production ratio by stimulated immune cells. Leukocytes have functional 5-HT1B receptors. 5-HT moduline, an endogenous 5-HT1B receptor antagonist, may antagonize the 5-HT1B agonist-induced proliferation of immune cells. Aims: To examine the effects of 5-HT moduline on the stimulated production of IFNgamma, tumor necrosis factor alpha (TNFalpha) and IL-10. Results: 5-HT moduline, 10(-6) M and 10(-5) M, significantly reduced the production of IFNgamma and the IFNgamma/IL-10 ratio. 5-HT moduline 10(-5)M significantly reduced the production of TNFa. The combination of 5-HT, 15 mug/mL, with 5-HT moduline, 10(-6) M and 10(-5) M, further decreases the IFNgamma/IL-10 production ratio. Interpretation: 5-HT moduline has negative immunoregulatory effects.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 50 条
  • [41] Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain
    Shalom, G
    Gur, E
    Van de Kar, LD
    Lerer, B
    Newman, ME
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S15 - S16
  • [42] Effects of a glucocorticoid receptor antagonist and an SSRI on 5-HT transporter binding and 5-HT1A receptor mRNA
    Johnson, D. A.
    Grant, E. J.
    Ingram, C. D.
    Gartside, S. E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S255 - S255
  • [43] 5-HT1A and 5-HT1B receptor agonists and aggression:: A pharmacological challenge of the serotonin deficiency hypothesis
    de Boer, SF
    Koolhaas, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 526 (1-3) : 125 - 139
  • [44] Interactions of GR127935, a 5-HT1B/D receptor ligand, with functional 5-HT receptors
    DeVries, P
    Apaydin, S
    Villalon, CM
    Heiligers, JPC
    Saxena, PR
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 423 - 430
  • [45] Synthesis of potent and selective serotonin 5-HT1B receptor ligands
    Huang, YY
    Bae, SA
    Roth, BL
    Laruelle, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4786 - 4789
  • [46] Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior
    Mancilla-Diaz, JM
    Escartin-Perez, RE
    Lopez-Alonso, VE
    Floran-Garduño, B
    Romano-Camacho, JB
    MEDICAL SCIENCE MONITOR, 2005, 11 (03): : BR74 - BR79
  • [47] Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line
    Ataee, Ramin
    Ajdary, Soheila
    Zarrindast, Mohammadreza
    Rezayat, Mehdi
    Hayatbakhsh, Mohammad Reza
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (10) : 1461 - 1469
  • [48] Role of 5-HT1B and 5-HT1D receptors in the regulation of 5-HT release in the rat CNS
    Greenslade, RG
    Bright, N
    Mitchell, SN
    MONITORING MOLECULES IN NEUROSCIENCE, 2001, : 339 - 340
  • [49] Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line
    Ramin Ataee
    Soheila Ajdary
    Mohammadreza Zarrindast
    Mehdi Rezayat
    Mohammad Reza Hayatbakhsh
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1461 - 1469
  • [50] SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist in native tissue
    Watson, J
    Roberts, C
    Scott, C
    Kendall, I
    Collin, L
    Day, NC
    Harries, MH
    Soffin, E
    Davies, CH
    Randall, AD
    Heightman, T
    Gaster, L
    Wyman, P
    Parker, C
    Price, GW
    Middlemiss, DN
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (06) : 797 - 806